Although islet transplantation is a promising approach for treating such cases, the only FDA-approved method to date has significant limitations. "This work lays the foundation for subcutaneous ...

Clinical islet transplantation is gaining acceptance as a potential therapy, particularly for subjects who have labile diabetes or problems with hypoglycemic awareness. The risks of the procedure ...

Currently, the common approach to islet transplantation involves injecting islets extracted from a donor pancreas into the hepatic portal vein, typically via a thin needle inserted into the liver ...

Researchers have developed a method using engineered blood vessel cells (R-VECs) to improve islet transplantation which could offer a safer and more effective treatment for type 1 diabetes. In a study ...

They have developed a novel pancreatic islet macroencapsulation system designed for subcutaneous transplantation, offering a promising solution for type 1 diabetes management. The work is ...

Although islet transplantation is a promising approach for treating such cases, the only FDA-approved method to date has significant limitations. In a study published Jan. 29 in Science Advances ...